BOT botanix pharmaceuticals ltd

Ann: FDA Approves Sofdra, page-531

  1. 3,033 Posts.
    lightbulb Created with Sketch. 799
    What we do not know :

    1. How much they will spend on marketing to target 6.7mln suffering people via Internet

    2. How many re-fills a patient will get per year- they say 6 ( but lets say 3) - accuracy 50% considering Insurance covers most of it anyway.



    as I posted earlier , we should get to 1% of the market in 12 months 100 000 sufferers ( considering Japan) and with 3 refills > we should sit at $ 2.3 per share

    if they get 6 re- fills $ 4.6 pet share .. Sales 13-15x valuation..
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
30.0¢
Change
0.015(5.26%)
Mkt cap ! $588.2M
Open High Low Value Volume
28.5¢ 30.0¢ 28.5¢ $2.754M 9.333M

Buyers (Bids)

No. Vol. Price($)
3 30000 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 755655 13
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.